A gRNA targeting HPK1 and a method for editing HPK1 gene

一种HPK-1、基因的技术,应用在分子生物学和免疫学领域,能够解决肿瘤杀伤力不足、T细胞衰竭、活性降低等问题

Active Publication Date: 2020-06-09
BEIJING YUFAN BIOTECH CO LTD
View PDF50 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main reason is T cell exhaustion, decreased activity, and insufficient tumor lethality. Therefore, discovering new T cell modification sites and modification methods in vitro, improving T cell activity and lethality, and inhibiting T cell exhaustion are future research and technological development. direction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A gRNA targeting HPK1 and a method for editing HPK1 gene
  • A gRNA targeting HPK1 and a method for editing HPK1 gene
  • A gRNA targeting HPK1 and a method for editing HPK1 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0321] Design and synthesis of embodiment 1.gRNA

[0322] 1. Design of guide RNA

[0323] The plasmid loaded with gRNA is pUC57kan-T7-gRNA, the gRNA targeting HPK1 was designed, and the gRNA targeting PD1 was used as a control. The sequence of the gRNA specifically targeting HPK1 paired with the genome is GACCTGGTGGCACTGAAGA (located at the second exon of HPK1, SEQ ID NO: 1); the sequence of the gRNA specifically targeting PD1 paired with the genome is GGCCAGGATGGTTCTTAGGT (located at the second exon of PD1 The first exon of , SEQ ID NO: 2).

[0324] HPK1 gRNA: F: 5′-TAGG GACCTGGTGGCACTGAAGA-3′ (SEQ ID NO: 3)

[0325] R: 5'-AAAC TCTTCAGTGCCACCAGGTC-3' (SEQ ID NO: 4)

[0326] PD1 gRNA: F: 5′-TAGG GGCCAGGATGGTTCTTAGGT-3′ (SEQ ID NO: 5)

[0327] R: 5'-AAAC ACCTAAGAACCATCCTGGCC-3' (SEQ ID NO: 6).

[0328] Synthesize the gRNA coding strand and the complementary strand by annealing the two DNA strands of HPK1 gRNA and PD1 gRNA to form a double-stranded DNA template, which is in...

Embodiment 2

[0334] Recombinant expression and purification of embodiment 2.Cas9 protein

[0335] Humanized Cas9 (sequences are provided in SEQ ID NOS: 18 and 19) was prepared according to methods reported in the literature. Chang, N et al., Cell Res. 23:465-472 (2013), the contents of which are incorporated herein by reference in their entirety, including the sequence of the humanized, codon-optimized Cas9 cDNA and the protein sequence reported therein. Briefly, the plasmid used to load Cas9 was PGEX4T-1, and a codon-optimized full-length human cas9 cDNA was obtained by PCR. The template is the plasmid pUC19-T7-CAS9. A nuclear localization signal (NLS) was added to the 5' and 3' ends of the Cas9 sequence to facilitate nuclear import of the cas9 protein.

[0336] After successfully constructing the plasmid, express the CAS9 protein by Escherichia coli, purify it through a GST column, concentrate and collect the protein, cut the GST tag by thrombin, and observe a protein band near the 160...

Embodiment 3

[0337] Example 3. In vitro expansion and transfection of human peripheral blood mononuclear cells

[0338] use Sodium diatrizoate solution was used to extract human peripheral blood mononuclear cells by centrifugation and rapid separation. CD3-positive peripheral blood mononuclear cells were sorted using CD3 magnetic beads, T cells were activated using CD3 / 28 antibody, and incubated in LONZA-X-VIVO 15 medium containing 100U / ml IL-2 at 37℃ / 5% CO 2 Viral transfection and electroporation were performed after 2 days of culture under the conditions of .

[0339] Mix cas9 protein and gRNA mRNA in a certain ratio, and let stand at room temperature for 10 minutes, meanwhile, mix 4.0×10 6 CD3+ T cells (activated with CD3 / CD28 antibody for 48 hours in vitro) were transferred to a 15ml centrifuge tube. Cells were centrifuged at 500 x g for 5 minutes and then resuspended in 400 μl optimized medium (mixture containing cas9 and gRNA). The cell mixture was transferred to a BTX cuvette ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a gRNA targeting HPK1 and a method for editing HPK1 gene. The method can knock out the T cell HPK1 gene, enhance the T cell killing activity, increase the Th1 cytokine level of peripheralblood mononuclear cells, and knock out of the T cell HPK1 gene can also down-regulate the expression of PD-1 and TIM3 on the T cell surface and can inhibit the T cell depletion.

Description

[0001] Cross References to Related Applications [0002] This application claims the priority of Chinese Application No. 201710853090.2 filed on September 20, 2017, the contents of which are hereby incorporated by reference in their entirety. technical field [0003] In various embodiments, the present invention relates to the technical fields of molecular biology and immunology, and more particularly to cancer immunotherapy. For example, in various embodiments, the present invention generally relates to compositions and methods for editing the HPK1 gene, cells (such as T cells, NK cells, and NKT cells) having the edited HPK1 gene, pharmaceutical combinations comprising the cells and methods of using the pharmaceutical compositions, for example, for the treatment of cancer. Background technique [0004] Tumor is one of the major diseases that threaten human health. In recent years, immunotherapy against tumor has gradually become a research hotspot in tumor treatment. Tumo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C12N5/10
CPCA61K39/464406A61K39/4611A61K39/464412A61K39/4631A61K39/464417C07K14/7051C12N5/0645C12N9/12C12N9/22C12N15/1137C12N15/85C12Y207/11C07K2319/00C12N2310/10C12N2510/00C12N2800/80C12N2810/10A61K2239/48A61K2239/59A61K2239/38C12N5/0636A61K2239/31C12N15/10A61P35/00C12N2310/20C12Y207/11001C07K2319/09C07K2319/21C07K2319/23C07K2319/24C07K2319/50C12N15/90A61P37/04C07K2319/03A61K2121/00A61K2300/00
Inventor廖学斌司静文
OwnerBEIJING YUFAN BIOTECH CO LTD